Kanninen et al. reported that intrahippocampal injection of Nrf2 mitigated the spatial impairment of AD mice (APP/PS1 mice) associated with increased plaque formation and heme oxygenase-1 levels [96]. The gene discussed is APP; the disease is Alzheimer disease.